🎉 M&A multiples are live!
Check it out!

Clover Health Valuation Multiples

Discover revenue and EBITDA valuation multiples for Clover Health and similar public comparables like Molina Healthcare, Alignment Healthcare, and Dc Healthcare Holdings.

Clover Health Overview

About Clover Health

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.


Founded

2019

HQ

United States of America
Employees

570

Financials

LTM Revenue $1.6B

LTM EBITDA $64.1M

EV

$1.3B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Clover Health Financials

Clover Health has a last 12-month revenue (LTM) of $1.6B and a last 12-month EBITDA of $64.1M.

In the most recent fiscal year, Clover Health achieved revenue of $1.4B and an EBITDA of -$44.9M.

Clover Health expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Clover Health valuation multiples based on analyst estimates

Clover Health P&L

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $1.6B XXX $1.4B XXX XXX XXX
Gross Profit $1.6B XXX $365M XXX XXX XXX
Gross Margin 100% XXX 27% XXX XXX XXX
EBITDA $64.1M XXX -$44.9M XXX XXX XXX
EBITDA Margin 4% XXX -3% XXX XXX XXX
EBIT -$37.1M XXX -$45.5M XXX XXX XXX
EBIT Margin -2% XXX -3% XXX XXX XXX
Net Profit -$52.5M XXX -$43.0M XXX XXX XXX
Net Margin -3% XXX -3% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Clover Health Stock Performance

As of May 30, 2025, Clover Health's stock price is $3.

Clover Health has current market cap of $1.6B, and EV of $1.3B.

See Clover Health trading valuation data

Clover Health Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.3B $1.6B XXX XXX XXX XXX $-0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Clover Health Valuation Multiples

As of May 30, 2025, Clover Health has market cap of $1.6B and EV of $1.3B.

Clover Health's trades at 0.9x EV/Revenue multiple, and -28.2x EV/EBITDA.

Equity research analysts estimate Clover Health's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Clover Health has a P/E ratio of -30.4x.

See valuation multiples for Clover Health and 12K+ public comps

Clover Health Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $1.6B XXX $1.6B XXX XXX XXX
EV (current) $1.3B XXX $1.3B XXX XXX XXX
EV/Revenue 0.8x XXX 0.9x XXX XXX XXX
EV/EBITDA 19.8x XXX -28.2x XXX XXX XXX
EV/EBIT -34.2x XXX -27.9x XXX XXX XXX
EV/Gross Profit 0.8x XXX n/a XXX XXX XXX
P/E -30.4x XXX -37.2x XXX XXX XXX
EV/FCF 36.8x XXX 38.1x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Clover Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Clover Health Margins & Growth Rates

Clover Health's last 12 month revenue growth is 29%

Clover Health's revenue per employee in the last FY averaged $2.4M, while opex per employee averaged $0.7M for the same period.

Clover Health's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Clover Health's rule of X is 77% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Clover Health and other 12K+ public comps

Clover Health Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 29% XXX 29% XXX XXX XXX
EBITDA Margin 4% XXX -3% XXX XXX XXX
EBITDA Growth 8% XXX n/a XXX XXX XXX
Rule of 40 19% XXX 26% XXX XXX XXX
Bessemer Rule of X XXX XXX 77% XXX XXX XXX
Revenue per Employee XXX XXX $2.4M XXX XXX XXX
Opex per Employee XXX XXX $0.7M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 30% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Clover Health Public Comps

See public comps and valuation multiples for Managed Care and Health Data & Analytics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Genesis Fertility Center XXX XXX XXX XXX XXX XXX
Dc Healthcare Holdings XXX XXX XXX XXX XXX XXX
Health Italia XXX XXX XXX XXX XXX XXX
Alignment Healthcare XXX XXX XXX XXX XXX XXX
Molina Healthcare XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Clover Health M&A and Investment Activity

Clover Health acquired  XXX companies to date.

Last acquisition by Clover Health was  XXXXXXXX, XXXXX XXXXX XXXXXX . Clover Health acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Clover Health

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Clover Health

When was Clover Health founded? Clover Health was founded in 2019.
Where is Clover Health headquartered? Clover Health is headquartered in United States of America.
How many employees does Clover Health have? As of today, Clover Health has 570 employees.
Who is the CEO of Clover Health? Clover Health's CEO is Mr. Andrew Toy.
Is Clover Health publicy listed? Yes, Clover Health is a public company listed on NAS.
What is the stock symbol of Clover Health? Clover Health trades under CLOV ticker.
When did Clover Health go public? Clover Health went public in 2021.
Who are competitors of Clover Health? Similar companies to Clover Health include e.g. Genesis Fertility Center, Dc Healthcare Holdings, Health Italia, Alignment Healthcare.
What is the current market cap of Clover Health? Clover Health's current market cap is $1.6B
What is the current revenue of Clover Health? Clover Health's last 12 months revenue is $1.6B.
What is the current revenue growth of Clover Health? Clover Health revenue growth (NTM/LTM) is 29%.
What is the current EV/Revenue multiple of Clover Health? Current revenue multiple of Clover Health is 0.8x.
Is Clover Health profitable? Yes, Clover Health is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Clover Health? Clover Health's last 12 months EBITDA is $64.1M.
What is Clover Health's EBITDA margin? Clover Health's last 12 months EBITDA margin is 4%.
What is the current EV/EBITDA multiple of Clover Health? Current EBITDA multiple of Clover Health is 19.8x.
What is the current FCF of Clover Health? Clover Health's last 12 months FCF is $34.4M.
What is Clover Health's FCF margin? Clover Health's last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of Clover Health? Current FCF multiple of Clover Health is 36.8x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.